盎格鲁力学 ANGO 深 沪
已收盘 07-02 16:00:00 美东时间
13.09
+0.010
+0.08%
华盛通- 最 高13.40
- 今 开13.25
- 成交量 35.03万股
- 最 低 12.9319
- 昨 收 13.08
- 总市值 5.41亿
- 52周最高 13.99
- 市盈率 静 --
- 换手率 0.85%
- 52周最低 8.36
- 委 比 -61.05%
- 总股本 4131.89万
- 历史最高 32.00
- 量 比 0.82
- 振 幅 3.58%
- 历史最低 5.26
- 每 手 1
- 风险率 1.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's...
06-17 20:37
AngioDynamics wins FDA IDE approval for RELIEF feasibility study of NanoKnife in BPH
AngioDynamics wins FDA IDE approval for RELIEF feasibility study of NanoKnife in BPH AngioDynamics secured FDA IDE clearance to launch the RELIEF feasibility study of its NanoKnife IRE system for BPH-related urinary symptoms. Single-arm trial targets 40 patients across up to five US sites, with six-
06-17 20:31
Terra Innovatum Global N.V. GAAP EPS of $9.74
Terra Innovatum Global N.V. press release (NKLR): FY GAAP EPS of $9.74. Cash and cash equivalents were $102.9 million as of December 31, 2025, compared to $2.15 million as of September 30, 2025, prior...
06-16 05:43
AngioDynamics lifts FY2026 net sales outlook to $313.5-$315.5 million
AngioDynamics lifts FY2026 net sales outlook to $313.5-$315.5 million AngioDynamics raised FY 2026 net sales guidance to $313.5 million-$315.5 million from $312 million-$314 million. Med Tech net sales growth outlook lifted to 15%-17% from 14%-16%; Med Device growth forecast lifted to about 1% from
06-10 21:43
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock jumped 11.73%.
06-03 20:29
AngioDynamics Announces 2-Yr Results From PRESERVE Pivotal Trial Demonstrating Durable Oncologic Control And Sustained Safety Profile For NanoKnife System In Focal Ablation Of Intermediate-Risk Prostate Cancer
Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented at AUA 2026AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in
05-13 21:06
Venu Holding plans $300M Chattanooga amphitheater project
Venu Holding (VENU) on Tuesday said it entered an agreement to purchase a 15-acre site in Chattanooga, Tennessee, for the planned development of Sunset Amphitheater Chattanooga, a next-generation live...
05-12 23:18
Sidus Space prices $58.5M offering at $4.35 per share
Space and defense technology firm Sidus Space (SIDU) announced the pricing of a direct offering of ~13.4M shares at an offering price of $4.35 per share. Gross proceeds target $58.5M before placement ...
04-20 12:50
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
